Skin Elements has secured an exclusive New Zealand distribution agreement for its ECO-Nurture bio-stimulant, raised $1.47 million through options and placement, and refreshed its board after shareholder votes.
- Exclusive Farmlands distribution deal for ECO-Nurture
- Raised $1.47 million via options and placement
- Board renewal following shareholder meetings
- Operating cash outflows of $874k with $840k cash on hand
- Progressing regulatory approval in New Zealand
Exclusive NZ Distribution Agreement for ECO-Nurture
Skin Elements Limited (ASX:SKN) has taken a significant commercial step by signing an exclusive distribution agreement with New Zealand’s largest rural co-operative, Farmlands Co-Operative Society. This deal grants Farmlands exclusive rights to market, sell, and distribute ECO-Nurture, Skin Elements' all-natural horticultural bio-stimulant designed as an environmentally friendly alternative to chemical crop sprays.
An initial order for 4,000 litres worth NZ$600,000 (plus GST) has been placed, targeting the $5 billion New Zealand kiwifruit industry, which has been severely affected by the PSA bacteria. ECO-Nurture's independent trials over four growing seasons have demonstrated its efficacy in improving plant health and stress tolerance with biodegradable, plant-based ingredients. Skin Elements is actively pursuing New Zealand government approval under the Agricultural Compounds and Veterinary Medicines Act 1997 (ACVM), a prerequisite for broader national sales through Farmlands.
Capital Raising Bolsters Balance Sheet
During the quarter, Skin Elements raised $570,000 from the exercise of 95 million unlisted options at $0.006 each. Shortly after quarter-end, the company completed a $900,000 placement at $0.003 per share to sophisticated and professional investors, issuing 300 million shares under its existing ASX placement capacity. This brings total capital raised in the period to $1.47 million before costs, providing a vital cash injection to support ongoing commercialisation and regulatory activities.
Board Renewal Reflects Shareholder Direction
Skin Elements underwent a substantial board reshuffle following two Extraordinary General Meetings prompted by shareholder requisitions under section 249D of the Corporations Act. Shareholders removed directors Dr Peter Malone and Filippo Giglia, while appointing Frank Knezovic, Gorakanage Ishan Malinda Peries, and Harry Spindler as non-executive directors. Additionally, three directors; Stuart Usher, Robin Armstrong, and Brett Fraser; resigned prior to the second meeting. Executive Chairman Rod Nicholas and director Joshua Gordon were ratified in their roles, marking a clear shift in governance aligned with shareholder preferences.
Cash Flow and Operational Update
Skin Elements reported operating cash outflows of $874,000 for the quarter, with cash and equivalents ending at $840,000. The company’s cash burn was driven by $342,000 in product manufacturing, staff, and R&D expenses, alongside $240,000 in marketing and administration costs. Legal and corporate governance expenses related to the board changes added $230,000 to outflows. Despite this, the company expects reduced corporate costs going forward and anticipates revenue growth from its Farmlands distribution agreement.
Skin Elements also accessed a $288,000 R&D rebate advance facility from Radium Capital, secured against eligible R&D spend and repayable upon receipt of government rebates. This facility underpins ongoing development of the company’s SE FormulaTM biotechnology platform.
Regulatory Progress and Commercial Outlook
With ECO-Nurture advancing through New Zealand’s ACVM approval process, Skin Elements is positioning itself for broader market penetration via Farmlands’ national sales network. The company’s executive chairman emphasised the importance of this agreement in establishing a commercial footprint as Skin Elements pursues its wider growth strategy. The combination of capital raised, board renewal, and regulatory progress sets the stage for potential scaling of its natural antimicrobial biotechnology products.
Bottom Line?
Skin Elements’ recent capital raise and NZ distribution deal provide a foundation, but regulatory approval timing and cash runway under two quarters remain key near-term challenges.
Questions in the middle?
- How quickly will ECO-Nurture secure full ACVM approval to unlock nationwide New Zealand sales?
- Can Skin Elements sustain operations beyond the next quarter without further capital raises?
- Will the new board steer the company toward accelerated commercialisation and improved governance stability?